Quetiapine Extended Release Depression Symptoms

Clinical trial NCT00640562 · COMPLETED

Trial details

NCT number: NCT00640562
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Schizophrenia Depression

Start date: 2008-02-01
Primary completion: 2010-02-01
Enrollment: 216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.